JWA
PCRX icon

JFS Wealth Advisors’s Pacira BioSciences PCRX Stock Holding History

JFS Wealth Advisors’s Portfolio PCRX Stock Details PCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$153 Buy
+6
New +$142 ﹤0.01% 2188
2024
Q3 		– Sell
-21
Closed -$601 – 2006
2024
Q2 		$601 Hold
21
– – ﹤0.01% 1780
2024
Q1 		$614 Hold
21
– – ﹤0.01% 1749
2023
Q4 		$709 Buy
21
+20
+2,000% +$585 ﹤0.01% 1727
2023
Q3 		$31 Sell
1
-16
-94% -$577 ﹤0.01% 1947
2023
Q2 		$682 Sell
17
-4
-19% -$165 ﹤0.01% 1703
2023
Q1 		$858 Buy
21
+3
+17% +$119 ﹤0.01% 1623
2022
Q4 		$695 Buy
18
+10
+125% +$487 ﹤0.01% 1680
2022
Q3 		$0 Sell
8
-4
-33% -$222 ﹤0.01% 1874
2022
Q2 		$1K Sell
12
-3
-20% -$197 ﹤0.01% 1609
2022
Q1 		$1K Buy
15
+9
+150% +$600 ﹤0.01% 1701
2021
Q4 		$0 Buy
+6
New +$331 ﹤0.01% 1836

Other funds holding PCRX

HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $77B AUM 50.57% 1-Year Est. Return
WCM
Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.12B AUM 34.21% 1-Year Est. Return
1IA
1620 Investment Advisors Plymouth, Massachusetts $161M AUM 30.15% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return
CMA
Cedar Mountain Advisors Lake Oswego, Oregon $581M AUM 18.16% 1-Year Est. Return